Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization

This publication has 38 references indexed in Scilit:

• BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
  Thorax, 2001
• Guidelines for the Management of Adults with Community-acquired Pneumonia
  American Journal of Respiratory and Critical Care Medicine, 2001
• Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials
  Clinical Therapeutics, 2001
• Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia
  American Journal of Health-System Pharmacy, 2000
• Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
  Clinical Infectious Diseases, 2000
• Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
  Clinical Infectious Diseases, 2000
• Management of Community-Acquired Pneumonia in the Era of Pneumococcal Resistance
  Archives of internal medicine (1960), 2000
• A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia
  Antimicrobial Agents and Chemotherapy, 1997
• Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group
  Archives of internal medicine (1960), 1997
• Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.
  Thorax, 1996